The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applications

Author

  • F. J. T. Staal
  • C. Baum
  • C. Cowan
  • E. Dzierzak
  • S. Hacein-Bey-Abina
  • Stefan Karlsson
  • T. Lapidot
  • I. Lemischka
  • S. Mendez-Ferrer
  • H. Mikkers
  • K. Moore
  • E. Moreno
  • C. L. Mummery
  • C. Robin
  • T. Suda
  • M. Van Pel
  • G. Vanden Brink
  • J. J. Zwaginga
  • W. E. Fibbe

Summary, in English

The hematopoietic stem cell (HSC) is the prototype organ-regenerating stem cell (SC), and by far the most studied type of SC in the body. Currently, HSC-based therapy is the only routinely used SC therapy; however, advances in the field of embryonic SCs and induced pluripotent SCs may change this situation. Interest into in vitro generation of HSCs, including signals for HSC expansion and differentiation from these more primitive SCs, as well as advances in other organ-specific SCs, in particular the intestine, provide promising new applications for SC therapies. Here, we review the basic principles of different SC systems, and on the basis of the experience with HSC-based SC therapy, provide recommendations for clinical application of emerging SC technologies. Leukemia (2011) 25, 1095-1102; doi:10.1038/leu.2011.52; published online 29 April 2011

Publishing year

2011

Language

English

Pages

1095-1102

Publication/Series

Leukemia

Volume

25

Issue

7

Document type

Journal article review

Publisher

Nature Publishing Group

Topic

  • Cancer and Oncology

Keywords

  • stem cell
  • iPS
  • gene therapy
  • embryonic stem cell
  • transplantation

Status

Published

ISBN/ISSN/Other

  • ISSN: 1476-5551